We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Urology

Journal Scan / Research · November 18, 2020

Outcomes of SBRT vs LDR Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics

 

Additional Info

International Journal of Radiation Oncology*Biology*Physics
Biochemical Control and Toxicity Outcomes of SBRT vs LDR Brachytherapy in the Treatment of Low and Intermediate Risk Prostate Cancer
Int. J. Radiat. Oncol. Biol. Phys 2020 Nov 07;[EPub Ahead of Print], E Gogineni, Z Rana, D Soberman, B Sidiqi, V D'Andrea, L Lee, L Potters, B Parashar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading